Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
1. In this randomized controlled trial, infants who received a dose of azithromycin during their routine well visit had comparable mortality rates to placebo. 2. No differences were observed between the azithromycin and placebo groups with regard to rates of caregiver-reported hospitalization, sick-child clinic visits, or adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown:
According to a new systematic review and meta-analysis, roxadustat's efficacy remains consistent across varying inflammation levels in patients with chronic kidney disease.
1. In this randomized controlled trial, the Butantan-Dengue Vaccine (Butantan-DV) was effective in the prevention of symptomatic, virologically confirmed dengue after two years, regardless of baseline serostatus. 2. Butantan-DV was effective against DENV-1 and DENV-2 serotypes across all age groups. Evidence Rating Level: 2 (Good) Study Rundown: Dengue is a mosquito-borne viral illness that can
1. In this randomized controlled trial, patients experiencing symptomatic coronavirus disease 2019 (COVID-19) saw significant improvement in symptom resolution times compared to the placebo group. 2. Further investigation is needed to specifically delineate the impact of simnotrelvir on older COVID-19 patients. Evidence Rating Level: 1 (Excellent) Study Rundown: COVID-19 has been a major public health
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy exposed to acoramidis had slower disease progression than those on a placebo. 2. There were significantly fewer adverse events in the acoramidis group, along with a higher quality of life. Evidence Rating Level: 1 (Excellent) Study Rundown: TTR is a transport protein with